David John Mayers - Net Worth and Insider Trading
David John Mayers Net Worth
The estimated net worth of David John Mayers is at least $59,590 dollars as of 2024-11-13. David John Mayers is the Senior Officer of Neptune Wellness Solutions Inc and owns about 29,000 shares of Neptune Wellness Solutions Inc (TSX:NEPT) stock worth over $57,130. David John Mayers is also the Senior Officer of MediPharm Labs Corp and owns about 32,800 shares of MediPharm Labs Corp (TSX:LABS) stock worth over $2,460. Details can be seen in David John Mayers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David John Mayers has not made any transactions after 2020-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David John Mayers
David John Mayers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David John Mayers owns 2 companies in total, including MediPharm Labs Corp (TSX:LABS) , and Neptune Wellness Solutions Inc (TSX:NEPT) .
Click here to see the complete history of David John Mayers’s form 4 insider trades.
Insider Ownership Summary of David John Mayers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:LABS | MediPharm Labs Corp | 2018-11-05 | Senior Officer |
| TSX:NEPT | Neptune Wellness Solutions Inc | 2020-06-17 | Senior Officer |
David John Mayers Latest Holdings Summary
David John Mayers currently owns a total of 2 stocks. Among these stocks, David John Mayers owns 29,000 shares of Neptune Wellness Solutions Inc (TSX:NEPT) as of June 17, 2020, with a value of $57,130 and a weighting of 95.87%. David John Mayers also owns 32,800 shares of MediPharm Labs Corp (TSX:LABS) as of November 5, 2018, with a value of $2,460 and a weighting of 4.13%.
Latest Holdings of David John Mayers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:NEPT | Neptune Wellness Solutions Inc | 2020-06-17 | 29,000 | 1.97 | 57,130 |
| TSX:LABS | MediPharm Labs Corp | 2018-11-05 | 32,800 | 0.08 | 2,460 |
Holding Weightings of David John Mayers
David John Mayers Form 4 Trading Tracker
According to the SEC Form 4 filings, David John Mayers has made a total of 2 transactions in Neptune Wellness Solutions Inc (TSX:NEPT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Neptune Wellness Solutions Inc is the acquisition of 29,000 shares on June 17, 2020, which cost David John Mayers around $4 Million.
According to the SEC Form 4 filings, David John Mayers has made a total of 0 transactions in MediPharm Labs Corp (TSX:LABS) over the past 5 years. The most-recent trade in MediPharm Labs Corp is the acquisition of 32,800 shares on November 5, 2018, which cost David John Mayers around $49,856.
Insider Trading History of David John Mayers
- 1
David John Mayers Trading Performance
GuruFocus tracks the stock performance after each of David John Mayers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David John Mayers is 14.74%. GuruFocus also compares David John Mayers's trading performance to market benchmark return within the same time period. The performance of stocks bought by David John Mayers within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David John Mayers's insider trading performs compared to the benchmark.
Performance of David John Mayers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.19 | | | | | |
| Relative Return to S&P 500(%) | -3.78 | | | | | |
David John Mayers Ownership Network
Ownership Network List of David John Mayers
Ownership Network Relation of David John Mayers
David John Mayers Owned Company Details
What does MediPharm Labs Corp do?
Who are the key executives at MediPharm Labs Corp?
David John Mayers is the Senior Officer of MediPharm Labs Corp. Other key executives at MediPharm Labs Corp include Senior Officer Gregory Edison Hunter , Director & Senior Officer David Pidduck , and Director & Senior Officer Bryan Howcroft .
MediPharm Labs Corp (TSX:LABS) Insider Trades Summary
Over the past 18 months, David John Mayers made no insider transaction in MediPharm Labs Corp (TSX:LABS). Other recent insider transactions involving MediPharm Labs Corp (TSX:LABS) include a net sale of 399,773 shares made by Keith Strachan , a net sale of 2,031,162 shares made by David Pidduck , and a net sale of 211,257 shares made by Gregory Edison Hunter .
In summary, during the past 3 months, insiders sold 0 shares of MediPharm Labs Corp (TSX:LABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,642,192 shares of MediPharm Labs Corp (TSX:LABS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,642,192 shares.
MediPharm Labs Corp (TSX:LABS)'s detailed insider trading history can be found in Insider Trading Tracker table.
MediPharm Labs Corp Insider Transactions
David John Mayers Mailing Address
Above is the net worth, insider trading, and ownership report for David John Mayers. Currently GuruFocus does not have mailing address information for David John Mayers.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
